iSpecimen
ISPC
13 hedge funds and large institutions have $665K invested in iSpecimen in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 0 closing their positions.
18% more funds holding
Funds holding: 11 → 13 (+2)
2% more capital invested
Capital invested by funds: $653K → $665K (+$12.4K)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$20.6K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$19.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.64K |
| 2 |
TA
Teton Advisors
Rye,
New York
|
-$2.43K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.22K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.22K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$16 |
ISPC Hedge Fund Activity: Q1 2023 in Review
13 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q1 2023, worth a combined $665K — up 1.9% from $653K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ISPC positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 4 trimmed.
The largest buyer was Northern Trust, opening a new position worth an estimated $20.6K. The largest seller was Tower Research Capital (TRC), cutting an estimated $3.64K.
- 13 institutional investors held iSpecimen (ISPC) as of Q1 2023, up from 11 in Q4 2022.
- Funds reported $665K of iSpecimen stock for Q1 2023, up 1.9% quarter-over-quarter.
- 2 funds opened new iSpecimen positions in Q1 2023 and 0 closed out, a net change of +2 holders.
- The largest iSpecimen buyer in Q1 2023 was Northern Trust, an estimated $20.6K added.
- The largest iSpecimen seller in Q1 2023 was Tower Research Capital (TRC), an estimated $3.64K sold.
Based on aggregated 13F filings for Q1 2023.